Abbott's Growth Prospects Look Favorable for 2018
Narrow-moat Abbott posted strong fourth-quarter results that exceeded our expectations, and we anticipate moderately raising our fair value estimate to reflect more optimistic projections for the firm’s lineup of new product launches. With the long-awaited pipeline products from legacy St. Jude finally reaching commercialization, we think growth prospects for medical devices through the midterm look rosy for Abbott. In general, the firm continues to make progress on improving its profitability, ...
Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.
Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.
We have operations in 27 countries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.